Bill

Premenstrual Dysphoric Disorder Awareness and Research Act of...

HB8160HealthFiled

To expand research, improve awareness, and increase access to treatment for individuals affected by Premenstrual Dysphoric Disorder, and for other purposes.

Filed
In Committee
Passed Chamber
Final Approval

HB8160 aims to improve research, raise awareness, and increase access to treatment for individuals with Premenstrual Dysphoric Disorder (PMDD). PMDD is a severe form of premenstrual syndrome that can significantly affect a person's quality of life. The bill seeks to address gaps in understanding and treatment of this condition.

This bill will affect individuals who suffer from PMDD, particularly women, by providing better research funding, increasing public awareness, and improving access to treatment options. This could lead to earlier diagnosis, more effective treatments, and better overall support for those affected.

As of March 30, 2026, HB8160 has been introduced in the House and referred to the House Committee on Energy and Commerce. The bill is currently in the initial stages of the legislative process, awaiting further review and potential action by the committee.